NIH-funded research Career grant

Helping adults with intellectual disabilities quit smoking

Official title: Adapting and Testing a Smoking Cessation Intervention in Adults with Intellectual and Developmental Disabilities

Funded at University of Kentucky · NIH-10865580 · Data updated 2026-11-12

This study is working on a special program to help adults with intellectual and developmental disabilities quit smoking, by understanding their unique challenges and creating a supportive environment just for them.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startJuly 1, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$124,919
NIH project number1K99DA060267-01
Project IDNIH-10865580 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who have intellectual and developmental disabilities and are current smokers.

Less likely to help

Patients who do not have intellectual or developmental disabilities or who are not smokers may not benefit from this research.

What this research studies

This research focuses on developing and testing a smoking cessation program specifically designed for adults with intellectual and developmental disabilities (IDDs). It aims to understand the unique challenges faced by this population in quitting smoking and to adapt existing evidence-based interventions to better meet their needs. By engaging with the community, the research seeks to identify barriers to treatment and create a supportive environment for individuals trying to quit. The ultimate goal is to improve health outcomes for adults with IDDs who smoke.

Why it matters

Potential benefit: If successful, this research could lead to more effective smoking cessation strategies tailored for adults with intellectual disabilities, improving their overall health and quality of life.

How similar studies have gone: While smoking cessation interventions have been successful in the general population, this approach specifically targeting individuals with IDDs is novel and has not been extensively tested.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Regnier, Sean — University of Kentucky
  • Study coordinator: Regnier, Sean

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.